Kidney Disease

The American Kidney Fund has launched the Rare Kidney Disease Action Network, an advocacy initiative for patients with rare conditions, according to a press release.

Rates of potassium-based sodium substitutes were higher in products with a “reduced sodium” claim compared with other sodium content claim categories, according to published data.

A bill in the U.S. House of Representatives that would slow efforts by commercial health plans from moving patients with end-stage kidney disease to Medicare now has 30 co-sponsors, according to a press release.

PHILADELPHIA — There are 32 proteins that could be of interest to help predict focal segmental glomerulosclerosis recurrence in patients with kidney disease, according to presented data.

Among older adults participating in the Systolic Blood Pressure Intervention Trial, a low eGFR without albuminuria was associated with a higher mortality rate but not with increased risk of cardiovascular events, results showed.

Members of the U.S. Senate have reintroduced a bill that would provide Medicare funding for preventive screenings for kidney disease, add payments for innovative devices and allow patients younger than 65 years to buy Medigap coverage.

Multidisciplinary experts from across cardiometabolic subspecialties will gather again to showcase the latest clinical research at the Heart in Diabetes CME Conference.

In a study of Medicare beneficiaries, researchers from Brigham and Women’s Hospital found that 6% of patients treated for heart failure progressed to dialysis within 1 year after hospitalization.

Patients with chronic kidney disease who received medication to treat their depression did not see a reduction in adverse health risks for hospitalizations and mortality, a recently published study shows.

Use of the drug semaglutide in patients with type 2 diabetes significantly reduced the risk of major kidney disease events, cardiovascular outcomes and all-cause mortality vs. placebo, newly published data show.